InvestorsHub Logo
Followers 10
Posts 1265
Boards Moderated 0
Alias Born 11/10/2015

Re: pharmeng post# 87821

Friday, 12/14/2018 1:39:14 PM

Friday, December 14, 2018 1:39:14 PM

Post# of 108192
Far as I can tell, they have one cell therapy in their pipeline now, which is a small CAR-T program in phase 1 being developed in house.

Clearly, cell therapy is not a high priority for them. That does NOT make this good news or anything, other than to say they may not have been the right partner after all. For now, we suffer the paper loss
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News